AtriCure, Inc. (ATRC)

AtriCure Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-30.44	-46.47	50.2	-48.16	-35.19
Depreciation & Amortization	14.81	11.71	10.44	9.55	9.37
Share-Based Compensation	35.73	28.77	28.08	22.64	17.98
Other Operating Activities	-15.62	-16.16	-102.5	-3.9	-7.96
Operating Cash Flow	4.48	-22.14	-13.78	-19.87	-15.81
Capital Expenditures	-42	-16.88	-9.75	-5.26	-12.14
Acquisitions	0	0	0	0	-17.24
Change in Investments	63.82	60.89	33.26	-151.74	27.24
Other Investing Activities	-	-	-	0.8	-
Investing Cash Flow	21.82	44.01	23.5	-156.2	-2.15
Share Issuance / Repurchase	1.02	-6.16	-5.66	190.09	-5.17
Debt Issued / Paid	-0.99	-0.9	-0.82	-0.67	19.87
Other Financing Activities	-0.06	-	-1.17	-0.04	-0.33
Financing Cash Flow	-0.03	-7.06	-7.64	189.39	14.37
Exchange Rate Effect	-0.06	-0.36	-0.37	0.14	-0.16
Net Cash Flow	26.21	14.45	1.71	13.46	-3.75
Free Cash Flow	-37.51	-39.02	-23.53	-25.13	-27.95
Free Cash Flow Margin	-9.40%	-11.81%	-8.58%	-12.17%	-12.11%
Free Cash Flow Per Share	-0.81	-0.85	-0.52	-0.60	-0.74

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).